CS logo
small CS logo
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si

Brisbane, Queensland, Australia
Hospital in Herston, Queensland
Butterfield St, Herston QLD 4029
929 Beds

About Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si


The Royal Brisbane and Women's Hospital is a tertiary hospital located in Herston, a suburb of Brisbane, Queensland, Australia. It is operated by Queensland Health, a department of the Queensland Government.
There are 929 beds in Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
4
Hoffmann-La Roche
3
Total Rows: 2

Clinical Trials at Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si


During the past decade, Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11002200000022220000000000111100Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
2015-10-05
2022-06-14
Completed
809
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
2017-01-10
2022-12-20
Completed
772
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
2017-01-03
2022-12-08
Completed
778
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
2021-02-23
2025-10-22
Active, not recruiting
152
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
2021-03-29
2024-01-11
Active, not recruiting
434
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
2022-02-03
2026-07-17
Recruiting
350
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
2022-03-15
2030-01-25
Recruiting
1,600

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsMerck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4Hoffmann-La Roche: 3Hoffmann-La Roche: 3

Created with Highcharts 11.1.0Top CollaboratorsEisai Inc.: 2Eisai Inc.: 2European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1Gynecologic Oncology Group: 1Gynecologic Oncology Group: 1

Clinical Trials Conditions at Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si


According to Clinical.Site data, the most researched conditions in "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si" are "Renal Cell Carcinoma" (2 trials), "Carcinoma, Transitional Cell" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials), "Colorectal Neoplasms" (1 trials) and "Endometrial Neoplasms" (1 trials). Many other conditions were trialed in "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si" in a lesser frequency.

Clinical Trials Intervention Types at Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si


Most popular intervention types in "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si" are "Drug" (7 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials), "pembrolizumab" (2 trials) and "Belzutifan" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si


The vast majority of trials in "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si


Currently, there are NaN active trials in "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Active, not recruiting: 2Active, not recruiting: 2Recruiting: 2Recruiting: 2